Albumin Market Applications, Dynamics, Development Status and Outlook 2030
Talorsmith2821 Nov, 2022News
Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in Europe.
Related Bookmarks
- Steam Autoclave Market Competitive Landscape and Market Poised for Rapid Growth by 2030
- Genotyping Market Share, Key Players Review, Demand and Upcoming Trend by Forecast to 2030
- Houston SEO Services Can Help Businesses Grow Online
- Genotyping Market Size, In-Depth Analysis, Specifications and Forecast to 2030
- Genotyping Market Size, Technological Advancement, Development Status and Strategic Assessment 2030
- Genotyping Market Applications, Dynamics, Development Status and Outlook 2030
- Genotyping Market Demands, Overview, Component, Market Revenue and Forecast by 2030
- Aptamers Market Trends, Key Players Review, Demand and by Forecast to 2030
- Aptamers Market Size, Grow with a Healthy CAGR During Forecast Period 2030
- Aptamers Market Opportunities, Demand, Growth, Application and Forecast to 2030
Recent Profiles
The Energy People
Aaa Hauling
789bet
Tnt Mac Os
Kz88
Stove Wizard Australia Pty Ltd
Nirwan University Jaipur
23win
Uu88games Com
Kubet